NYSE$KVUE

Kenvue Inc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Headline financials

Total Revenue

$3.85B

Previous: $3.59B+7.3%
EPS (adj)

$0.27

Previous: $0.28-3.4%
Organic Sales Growth

11.2%

No prior period
Capital Expenditures

-$55M

No prior period
Free Cash Flow

$275M

No prior period
Net Income

$330M

Previous: $528M-37.5%
Operating Income

$640M

Previous: $611M+4.7%
Gross Profit

$2.13B

Previous: $1.96B+8.6%
Cash & Equivalents

$1.69B

No prior period
Total Assets

$35.6B

No prior period
Stock-Based Comp

$35M

No prior period

Revenue & EPS history

Kenvue · Revenue · Quarterly

$3.85B

Q1 2023+7.3%vs Q1 2022
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

Kenvue · $3.85B total across 3 segments · Q1 2023

  • Self Care
    $1.64B
  • Skin Health & Beauty
    $1.11B
  • Essential Health
    $1.1B

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 13 quarterly earnings reports

Historical avg

+2.0%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+2.8%

Avg return

30 days after

57%

8 / 14 earnings

Positive

+15.7%

Q3 2025

Best reaction

-7.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-1.2%+0.2%
Q4 2025+0.9%+2.9%-5.5%
Q3 2025+15.7%+17.5%+18.1%
Q2 2025+1.5%+2.1%-13.2%
Q1 2025+4.3%+2.4%-6.0%
Q4 2024-4.5%+0.8%+12.9%
Q3 2024+5.2%+5.1%+1.5%
Q2 2024+13.4%+15.6%+23.7%
Q1 2024+7.2%+7.7%-2.4%
Q4 2022-0.2%+3.1%+12.9%
Q4 2023-5.8%-6.2%-2.4%
Q3 2023-7.7%-5.7%+2.6%
Q2 2023-4.0%+0.5%-8.5%
Q1 2023-0.5%-0.8%+4.5%
Q3 2022
Q2 2022
Q1 2022
Q4 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro